Much lower HIV knowledge and access to testing for people with disabilities globally
Uganda achieves rapid scale-up of cervical screening for women living with HIV
Dolutegravir resistance very rare after a switch - even with detectable HIV
Most people on dolutegravir resuppress viral load after a detectable result
Lamivudine resistance mutation may persist for many years in some people with HIV
Thank you and farewell
Five ways healthcare providers can show that they respect their patients living with HIV
Retention in HIV care has declined since 'Treat All' guidelines introduced
Belgian study asks: is it worth treating asymptomatic STIs?
